Increased fibrin monomer plasma concentration in stable coronary artery disease in patients without oral anticoagulation

Atherosclerosis

Volumn 157, Issue 2, 2001, Pages 417-422

  Redondo, Maurice ^a   Caliezi, Christoph ^a   Biasiutti, Franziska Demarmels ^a   Lämmle, Bernhard ^a   Wuillemin, Walter A ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Division of Hematology   (Switzerland)

Author keywords

Blood coagulation; Fibrin monomer; Myocardial infarction

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER; FIBRIN; MONOMER; THROMBIN;

ADULT; AGE; AGED; ARTICLE; BLOOD CLOTTING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SEX DIFFERENCE; THROMBOGENESIS;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICOAGULANTS; CORONARY DISEASE; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; REFERENCE VALUES; RISK;

EID: 0034906060     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00731-0     Document Type: Article

References (48)

1. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death
2. Coronary angioscopy in patients with unstable angina pectoris
3. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes
4. The contribution of thrombosis to the clinical expression of coronary atherosclerosis
5. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts)
6. The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts)
7. Haemostatic function and ischaemic heart disease: Principal results of the northwick park heart study
8. Fibrinogen and risk of cardiovascular disease
9. Increased activation of the haemostatic system in men at high risk of fatal coronary artery disease
10. Hemostatic risk factors in arterial thrombosis and atherosclerosis: The thrombin-fibrin and platelet-vWF axis
11. Family history of coronary heart disease and hemostatic variables in middle-aged adults
12. Epidemiology of coagulation factors, inhibitors and activation markers: The third Glasgow MONICA Survey II relationships to cardiovascular risk factors and prevalent cardiovascular disease
13. Fibrinopeptide a and platelet factor levels in unstable angina pectoris
14. Association between time of increased fibrinopeptide a levels in plasma and episodes of spontaneous angina: A controlled prospective study
15. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction
16. Fibrin generation and digestion in patients with angina pectoris
17. Thrombin activity and early outcome in unstable angina pectoris
18. Procoagulant and proinflammatory activity in acute coronary syndromes
19. Measurement of prethrombotic markers in the assessment of aquired hypercoagulable states
20. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: Relation to the presence and severity of coronary atherosclerosis
21. Enhanced coagulation activation in troponin T-positive unstable angina pectoris
22. Prothrombin fragments F1 + 2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis
23. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction
24. Activation parameters of blood coagulation in medical and surgical patients developping DVT: Evaluation of a new fibrin monomer ELISA
25. Can laboratory testing improve screening strategies for deep vein thrombosis at an emergency unit
26. The value of quantitative fibrin monomer determination in the early diagnosis of postoperative deep vein thrombosis
27. Performance of a new fibrin monomer assay to exclude deep vein thrombosis in symptomatic outpatients
28. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation
29. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation
30. Markers of coagulation and fibrinolysis after fractures of the lower extremities
31. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers
32. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease
33. Prothrombin fragment 1 + 2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation
34. 506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency
35. Heightened thrombin generation in individuals with resistance to activated protein C
36. Coagulation factors II, V, VII and X, prothrombin gene 20210G → A transition and factor V Leiden in coronary artery disease: High factor V clotting activity is an independent risk factor for myocardial infarction
37. Comparison of immunological and functional assays for measurement of soluble fibrin
38. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo
39. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
40. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis
41. A commom genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
42. Alteration of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris
43. Plasma concentration of coagulation and fibrinolysis factors and platelet function in hypertension
44. Coagulation activation in diabetes mellitus
45. Increased soluble fibrin monomer and soluble thrombomodulin levels in non-dependent diabetes mellitus
46. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke
47. Factor V Leiden in Greek thrombophilic patients: Relationship with actvated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1 + 2
48. Clinical studies and thrombin generation in patients homzygous or heterozygous for the G20210A mutation in the prothrombin gene